v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series B
Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2024 $ 200 $ 308 $ 59,649,645 $ (397,969) $ (52,373,248) $ (2,137,789) $ 4,741,147
Balance (in Shares) at Dec. 31, 2024 2,000,000 3,076,274 139          
Balance (in Shares) at Dec. 31, 2024         66,945      
Accretion of stock-based compensation in connection with stock option grants 155,054 155,054
Issuance of common stock for cash, net of allocated offering costs of $568,000 $ 120 4,531,880 4,532,000
Issuance of common stock for cash, net of allocated offering costs of $568,000 (in Shares)   1,200,000            
Initial recording on noncontrolling interest 188,810 (188,810)
Net loss for the period (1,473,196) (145,914) (1,619,110)
Balance at Mar. 31, 2025 $ 200 $ 428 64,525,389 $ (397,969) (53,846,444) (2,472,513) 7,809,091
Balance (in Shares) at Mar. 31, 2025 2,000,000 4,276,274 139          
Balance (in Shares) at Mar. 31, 2025         66,945      
Balance at Dec. 31, 2025 $ 433 61,482,739 $ (397,969) (54,980,520) $ 6,104,683
Balance (in Shares) at Dec. 31, 2025 4,331,274 139          
Balance (in Shares) at Dec. 31, 2025         66,945     66,945
Accretion of stock-based compensation in connection with stock option grants 225,861 $ 225,861
Accretion of stock-based professional fees in connection with stock option grants   6,104 6,104
Issuance of common shares for services $ 6 110,994 111,000
Issuance of common shares for services (in Shares)   60,000            
Issuance of warrants for services 279,975 279,975
Net loss for the period   (2,861,610) (2,861,610)
Balance at Mar. 31, 2026   $ 439 $ 62,105,673 $ (397,969) $ (57,842,130) $ 3,866,013
Balance (in Shares) at Mar. 31, 2026   4,391,274 139          
Balance (in Shares) at Mar. 31, 2026         66,945     66,945